Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine in pregnancy.

M Aubé1

  • 1McGill University and the Montréal Neurological Institute, Quebec, Canada.

Neurology
|September 16, 1999
PubMed
Summary
This summary is machine-generated.

Migraine in pregnancy generally does not increase risks for mother or fetus. Most women experience migraine improvement or remission during pregnancy, with specific types more likely to remit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensory stores and high-speed scanning.

Memory & cognition·2013
Same author

α-[11C] methyl-L tryptophan-PET as a surrogate for interictal cerebral serotonin synthesis in migraine without aura.

Cephalalgia : an international journal of headache·2013
Same author

Migraine and systemic vascular comorbidities.

Cephalalgia : an international journal of headache·2009
Same author

Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.

Neurology·2008
Same author

[The daily public health nursing practice: the Montreal infectious diseases unit as an example].

Sante publique (Vandoeuvre-les-Nancy, France)·2004
Same author

Non-obstructive hydrocephalus associated with intracranial schwannomas: hyperproteinorrhachia as an etiopathological factor?

Acta neurochirurgica·2003
Same journal

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same journal

Association of Changes in Intrinsic Capacity With Cognitive Decline and Dementia: A Prospective Cohort Study.

Neurology·2026
Same journal

Role of the Upper Motor Neuron in the Generation of Fasciculations in Early Disease Stages of Amyotrophic Lateral Sclerosis.

Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Obstetrics
  • Pharmacology

Background:

  • Migraine is a common neurological condition.
  • Pregnancy significantly impacts migraine frequency and severity for many women.
  • Understanding pregnancy-related migraine is crucial for maternal and fetal well-being.

Purpose of the Study:

  • To assess the impact of migraine on pregnancy outcomes.
  • To evaluate changes in migraine patterns during pregnancy.
  • To review safe management strategies for migraine during pregnancy.

Main Methods:

  • Review of retrospective studies on migraine and pregnancy outcomes.
  • Analysis of migraine improvement and worsening trends during gestation.
  • Examination of pharmacologic and non-pharmacologic treatment options.

Related Experiment Videos

Main Results:

  • Migraine does not elevate risks for toxemia, miscarriage, abnormal labor, congenital anomalies, or stillbirth.
  • 60-70% of women experience migraine improvement or remission, particularly in the second and third trimesters.
  • Migraine with aura is overrepresented in the small percentage of women whose migraines worsen or begin during pregnancy.

Conclusions:

  • Migraine is not associated with increased pregnancy complications.
  • Pregnancy often leads to migraine improvement, with specific patient profiles more likely to remit.
  • Safe management involves trigger avoidance, non-pharmacologic methods, and cautious use of specific medications.